JPRN-UMIN000002764已完成未知
Bronchodilator effects of salmeterol/fluticasone propionate (SFC) in patients with COPD - Bronchodilator effects of salmeterol/fluticasone propionate (SFC) in patients with COPD
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Asthma 2) Subjects had taken corticosteroids (either oral or inhaled) 3) Subjects had been suffering from COPD exacerbation. 4) Patients who are considered inappropriate by doctor.
研究者
相似试验
进行中（未招募）
不适用
Effects of bronchodilatation with salmeterol on the autonomic nervous systemChronic Obstructive Pulmonary Disease (COPD)MedDRA version: 14.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-001581-18-DEGlaxoSmithKline GmbH & Co. KG
已完成
不适用
The efficacy of salmeterol/fluticasone inhalation on systemic inflammatory markers in patients with chronic obstructive pulmonary diseaseschronic obstructive pulmonary diseasesJPRN-UMIN000008102Kawasaki Medical School60
已完成
4 期
Investigation of inhaled Salmeterol/ Fluticasone propionate (SFC) in patient with COPD.Chronic obstructive pulmonary diseaseJPRN-UMIN000006589Hamamatsu University School of Medicine342
已完成
不适用
sefulness of salmeterol/fluticasone combination (SFC) therapy in preschool children with uncontrolled asthma treated with inhaled corticosteroid.Preschool children with asthmaJPRN-UMIN000006770Dokkyo Medical University50
已完成
4 期
Effects of Salmeterol on Autonomic Nervous SystemPulmonary Disease, Chronic ObstructiveNCT01536587GlaxoSmithKline32